K. Shibayama

发表

Presence of serum anti-human T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy

S. Nagataki, M. Tsujihata, S. Shirabe, 1991, Journal of the Neurological Sciences.

Remarkable increase in CD26-positive T cells in patients with human T lymphotropic virus type I (HTLV-I) associated myelopathy.

S. Nagataki, K. Eguchi, M. Tsujihata, 1992, Internal medicine.

Interferon-alpha treatment in HTLV-I-associated myelopathy Studies of clinical and immunological aspects

S. Nagataki, M. Tsujihata, S. Shirabe, 1991, Journal of the Neurological Sciences.

Active production of anti-human T-lymphotropic virus type I (HTLV-I) IgM antibody in HTLV-I-associated myelopathy

S. Nagataki, M. Tsujihata, M. Motomura, 1991, Journal of Neuroimmunology.

Increased adherence of T cells to human endothelial cells in patients with human T-cell lymphotropic virus type I-associated myelopathy.

S. Nagataki, K. Eguchi, M. Tsujihata, 1992, Archives of neurology.

HTLV-I associated myelopathy in an identical twin

S. Nagataki, M. Tsujihata, M. Motomura, 1990, The Lancet.

PLASMAPHERESIS IN TREATMENT OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I ASSOCIATED MYELOPATHY

S. Nagataki, I. Tomita, A. Satoh, 1988, The Lancet.

The efficacy of interferon-alpha treatment in human T-lymphotropic virus type-I-associated myelopathy.

S. Nagataki, M. Tsujihata, T. Nakamura, 1990, Japanese journal of medicine.

Hippocampus and frontal cortex are the potential mediatory sites for convulsions induced by new quinolones and non-steroidal anti-inflammatory drugs.

S. Nagataki, M. Tsujihata, M. Motomura, 1991, International journal of clinical pharmacology, therapy and toxicology.

Locked-in syndrome and abnormal orientation of the right vertebral artery in a young man.

S. Nagataki, M. Tsujihata, T. Nakamura, 1994, Internal medicine.

Heparin treatment in patients with human T-lymphotropic virus type I (HTLV-I)-associated myelopathy: A preliminary study

S. Nagataki, K. Nagasato, Tatsufumi Nakamura, 1993, Journal of the Neurological Sciences.

Plasmapheresis to treat human T lymphotropic virus type I-associated myelopathy.

S. Nagataki, M. Tsujihata, M. Motomura, 1990, Current studies in hematology and blood transfusion.

LONG-TERM FOLLOW-UP OF IMMUNOMODULATION IN TREATMENT OF HTLV-I-ASSOCIATED MYELOPATHY

S. Nagataki, M. Tsujihata, H. Matsuo, 1989, The Lancet.

[A 46-year-old woman with myasthenia gravis associated with macromastia, erythroderma and hypogeusia].

S. Nagataki, M. Tsujihata, M. Motomura, 1994, Rinshō shinkeigaku Clinical neurology.